Here is a list of some of the most notable funding round announcements that took place this March in the provider technology ...
One year after the Medicaid continuous enrollment provision ended, 19.2 million people have been disenrolled from Medicaid, ...
Cancer drug developer Boundless Bio is a pioneer in therapies that target extrachromosomal DNA. The IPO cash will support its ...
The lack of adoption of interoperability tools by healthcare providers is a complex issue that requires a multi-faceted ...
This technology can result in reduced readmission rates, increased patient satisfaction, and a consistent flow of post-acute ...
At HIMSS24, Heather O'Sullivan, Mass General Brigham's president of healthcare at home, said that the health system wants to ...
FOLX Health, an LGBTQIA+ digital health provider, is working with Crisis Text Line to provide 24/7 text-based mental health ...
Merck drug Winrevair is the first in a new class of pulmonary arterial hypertension therapies that address a key signaling ...
Novocure said its “Tumor Treating Fields” met the main goal of a pivotal study enrolling non-small cell lung cancer patients ...
Geisinger’s chief data and informatics officer said health systems should spend more time designing their plan for evaluating ...
AI is meant to have a synergistic relationship with clinicians rather than replace them, pointed out David McSwain, chief ...
Disregarding novel developments on account of imperfection will postpone the advancement of scientific discovery.